The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes
Abstract
A long-standing paradox in cellular immunology concerns the conditional requirement for CD4+ T-helper (T(H)) cells in the priming of cytotoxic CD8+ T lymphocyte (CTL) responses in vivo. Whereas CTL responses against certain viruses can be primed in the absence of CD4+ T cells, others, such as those mediated through 'cross-priming' by host antigen-presenting cells, are dependent on T(H) cells. A clearer understanding of the contribution of T(H) cells to CTL development has been hampered by the fact that most T(H)-independent responses have been demonstrated ex vivo as primary cytotoxic effectors, whereas T(H)-dependent responses generally require secondary in vitro re-stimulation for their detection. Here, we have monitored the primary and secondary responses of T(H)-dependent and T(H)-independent CTLs and find in both cases that CD4+ T cells are dispensable for primary expansion of CD8+ T cells and their differentiation into cytotoxic effectors. However, secondary CTL expansion (that is, a secondary response upon re-encounter with antigen) is wholly dependent on the presence of T(H) cells during, but not after, priming. Our results demonstrate that T-cell help is 'programmed' into CD8+ T cells during priming, conferring on these cells a hallmark of immune response memory: the capacity for functional expansion on re-encounter with antigen.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The latter cell death is mediated by expression of the death ligand TRAIL, which triggers apoptosis in the helpless CTL as well as other activated T cells70,72.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [72]
In the citing paper
“In support of this, TRAIL-deficient mice were resistant to tolerance induction by intravenously injected apoptotic cells72.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [72]
In the citing paper
“As a result, the CD8+ T cells produce TRAIL upon re-exposure to antigen, which acts to inhibit immunization for cell-mediated responses (that is, mediate tolerance).”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [72]
In the citing paper
“DC that have engulfed necrotic cells present antigen to both CD4+ and CD8+ T cells, however those that engulf apoptotic cells present antigen to CD8+ T cells but not CD4+ T cells72.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [72]
Citations
Cites
Tolerance, Danger, and the Extended Family
Matzinger, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.005015 · Cited by 4,848
T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions
Schoenberger, S. P., Toes, R. E. M., van der Voort, E. I. H., Offringa, R., & Melief, C. J. M. (1998) · Nature · doi:10.1038/31002 · Cited by 2,615
Self-citationA conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell
Ridge, J. P., Rosa, F. D., & Matzinger, P. (1998) · Nature · doi:10.1038/30989 · Cited by 2,360
Help for cytotoxic-T-cell responses is mediated by CD40 signalling
Bennett, S. R. M., Carbone, F., Karamalis, F., Flavell, R. A., Miller, J. F. A. P., & Heath, W. R. (1998) · Nature · doi:10.1038/30996 · Cited by 2,091
Effector and memory T-cell differentiation: implications for vaccine development
Kaech, S. M., Wherry, E. J., & Ahmed, R. (2002) · Nature Reviews Immunology · doi:10.1038/nri778 · Cited by 1,865
Immunological memory and protective immunity: understanding their relation
Ahmed, R., & Gray, D. (1996) · Science · doi:10.1126/science.272.5258.54 · Cited by 1,775 · cited 1×
“Although transition through these stages was thought to be governed by the presence and eventual elimination of antigen, mounting evidence suggests that CD8 p T-cell development is guided by an instructional programme that, once set into motion during priming, is executed independentl”
BackgroundDialynas, D. P., Quan, Z., Wall, K. A., Pierrès, A., Quintáns, J., Loken, M. R., Pierres, M., & Fitch, F. W. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.131.5.2445 · Cited by 1,273
Kaech, S. M., & Ahmed, R. (2001) · Nature Immunology · doi:10.1038/87720 · Cited by 1,265
van Stipdonk, M. J. B., Lemmens, E. E., & Schoenberger, S. P. (2001) · Nature Immunology · doi:10.1038/87730 · Cited by 843
Self-citationT Cell-Dependent B Cell Activation
Parker, D. C. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.001555 · Cited by 739
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 1,000
HLA-Class II Artificial Antigen Presenting Cells in CD4+ T Cell-Based Immunotherapy
Couture, A., Garnier, A., Docagne, F., Boyer, O., Vivien, D., Mauff, B. L., Latouche, J., & Toutirais, O. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01081 · Cited by 97
Legat, A., Hajjami, H. M.-E., Baumgaertner, P., Cagnon, L., Maillard, S. A., Geldhof, C., Iancu, E. M., Lebon, L., Guillaume, P., Dojcinovic, D., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1212 · Cited by 93
Harnessing Tumor Mutations for Truly Individualized Cancer Vaccines
Vormehr, M., Türeci, Ö., & Şahin, U. (2019) · Annual Review of Medicine · doi:10.1146/annurev-med-042617-101816 · Cited by 93
Humphreys, I. R., Loewendorf, A. I., Trez, C. D., Schneider, K., Benedict, C. A., Munks, M. W., Ware, C. F., & Croft, M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.4.2195 · Cited by 92
Distinct Requirements for Deletion versus Anergy during CD8 T Cell Peripheral Tolerance In Vivo
Redmond, W. L., Marincek, B. C., & Sherman, L. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.4.2046 · Cited by 92
Huster, K. M., Koffler, M., Stemberger, C., Schiemann, M., Wagner, H., & Busch, D. H. (2006) · European Journal of Immunology · doi:10.1002/eji.200635874 · Cited by 91
Efficient T Cell Activation via a Toll-Interleukin 1 Receptor-Independent Pathway
Janssen, E. M., Tabeta, K., Barnes, M. J., Rutschmann, S., McBride, S. W., Bahjat, K. S., Schoenberger, S. P., Theofilopoulos, A. N., Beutler, B., & Hoebe, K. H. N. (2006) · Immunity · doi:10.1016/j.immuni.2006.03.024 · Cited by 94
Self-citationLee, B. O., Hartson, L., & Randall, T. D. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20031440 · Cited by 91
Marques, E. T. A., Chikhlikar, P. R., de Arruda, L. B., Leão, I. C., Yang, L., Wong, J., Chen, J.-S., Byrne, B. J., & August, J. T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303336200 · Cited by 91
Chemokine-Guided CD4+ T Cell Help Enhances Generation of IL-6RαhighIL-7Rαhigh Prememory CD8+ T Cells
Castellino, F., & Germain, R. N. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.2.778 · Cited by 90
Weldon, W. C., Zarnitsyn, V. G., Esser, E. S., Taherbhai, M. T., Koutsonanos, D. G., Vassilieva, E. V., Skountzou, I., Prausnitz, M. R., & Compans, R. W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041501 · Cited by 91
GM2 Expression in Renal Cell Carcinoma: Potential Role in Tumor-Induced T-Cell Dysfunction
Biswas, K., Richmond, A. L., Rayman, P. A., Biswas, S., Thornton, M., Sa, G., Das, T., Zhang, R., Chahlavi, A., Tannenbaum, C. S., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0250 · Cited by 90
Role of vitamin D in cytotoxic T lymphocyte immunity to pathogens and cancer
Sarkar, S., Hewison, M., Studzinski, G. P., Li, Y. C., & Kalia, V. (2015) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2015.1094443 · Cited by 90
Chen, Q., Jackson, H. M., Parente, P., Luke, T., Rizkalla, M., Tai, T. Y., Zhu, H., Mifsud, N. A., Dimopoulos, N., Masterman, K., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403271101 · Cited by 89
Northrop, J. K., Wells, A. D., & Shen, H. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.2.865 · Cited by 89
Lin, S.-W., Hensley, S. E., Tatsis, N., Lasaro, M. O., & Ertl, H. C. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci33138 · Cited by 88
Voo, K. S., Peng, G., Guo, Z., Fu, T., Li, Y., Frappier, L., & Wang, R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2552 · Cited by 92
Challenges in cancer vaccine development for hepatocellular carcinoma
Buonaguro, L., Petrizzo, A., Tagliamonte, M., Tornesello, M. L., & Buonaguro, F. M. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.05.031 · Cited by 87
Once a killer, always a killer: from cytotoxic T cell to memory cell
Lefrançois, L., & Obar, J. J. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2010.00895.x · Cited by 89
Redmond, W. L., Gough, M. J., Charbonneau, B., Ratliff, T. L., & Weinberg, A. D. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.11.7244 · Cited by 86
Dickkopf-1: A Promising Target for Cancer Immunotherapy
Chu, H. Y., Chen, Z., Wang, L., Zhang, Z., Tan, X., Liu, S., Zhang, B., Lü, A., Yu, Y., & Zhang, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.658097 · Cited by 88
CD8 T-Cell Memory Differentiation during Acute and Chronic Viral Infections
Kalia, V., Sarkar, S., & Ahmed, R. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6451-9_7 · Cited by 86
Piriou, E., van Dort, K. A., Nanlohy, N. M., van Oers, M. H. J., Miedema, F. F., & van Baarle, D. (2005) · Blood · doi:10.1182/blood-2005-01-0432 · Cited by 85
Therapeutic cancer vaccine: building the future from lessons of the past
Tran, T., Blanc, C., Granier, C., Saldmann, A., Tanchot, C., & Tartour, É. (2018) · Seminars in Immunopathology · doi:10.1007/s00281-018-0691-z · Cited by 85
Vaccination for Treatment and Prevention of Cancer in Animal Models
Cavallo, F., Offringa, R., van der Burg, S. H., Forni, G., & Melief, C. J. M. (2006) · Advances in immunology · doi:10.1016/s0065-2776(06)90005-4 · Cited by 83
Improving vaccines by incorporating immunological coadjuvants
Fraser, C. K., Diener, K. R., Brown, M. P., & Hayball, J. D. (2007) · Expert Review of Vaccines · doi:10.1586/14760584.6.4.559 · Cited by 83
Weldon, W. C., Martin, M. P., Zarnitsyn, V. G., Wang, B., Koutsonanos, D., Skountzou, I., Prausnitz, M. R., & Compans, R. W. (2011) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00435-10 · Cited by 83
Th1 and Th2 Cells Help CD8 T-Cell Responses
Ekkens, M. J., Shedlock, D. J., Jung, E., Troy, A. E., Pearce, E. L., Shen, H., & Pearce, E. J. (2007) · Infection and Immunity · doi:10.1128/iai.01328-06 · Cited by 93
Wilkie, G. M., Taylor, C., Jones, M. M., Burns, D. M., Turner, M., Kilpatrick, D., Amlot, P. L., Crawford, D., & Haque, T. (2004) · Journal of Immunotherapy · doi:10.1097/00002371-200407000-00007 · Cited by 83
Stock, S., Übelhart, R., Schubert, M., Fan, F., He, B., Hoffmann, J., Wang, L., Wang, S., Gong, W., Neuber, B., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32201 · Cited by 82
Komdeur, F. L., Singh, A. D., van de Wall, S., Meulenberg, J. J. M., Boerma, A., Hoogeboom, B. N., Paijens, S. T., Oyarce, C., de Bruyn, M., Schuuring, E. M. D., et al. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.11.002 · Cited by 82
Wuensch, S. A., Pierce, R. H., & Crispe, I. N. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.3.1689 · Cited by 82
Filatenkov, A., Jacovetty, E. L., Fischer, U. B., Curtsinger, J., Mescher, M. F., & Ingulli, E. G. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.11.6909 · Cited by 83
Progress in Defining CD4 Helper Cell Responses in Chronic Viral Infections
Day, C. L., & Walker, B. D. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20031947 · Cited by 82
Wang, J., Santosuosso, M., Ngai, P., Zganiacz, A., & Xing, Z. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.7.4590 · Cited by 82
Vaccine-Induced CD8+ Central Memory T Cells in Protection from Simian AIDS
Vaccari, M., Trindade, C. J., Venzon, D. J., Zanetti, M., & Franchini, G. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.6.3502 · Cited by 82
Mini‐review CD4 T cells are required for CD8 T cell memory generation
Bourgeois, C., & Tanchot, C. (2003) · European Journal of Immunology · doi:10.1002/eji.200324576 · Cited by 82
Functional assessment and specific depletion of alloreactive human T cells using flow cytometry
Martins, S. L. R., John, L. S. S., Champlin, R. E., Wieder, E., McMannis, J. D., Molldrem, J. J., & Komanduri, K. V. (2004) · Blood · doi:10.1182/blood-2004-05-1918 · Cited by 82
Okoye, I., Xu, L., Motamedi, M., Parashar, P., Walker, J. W. T., & Elahi, S. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001849 · Cited by 81
Virus‐like particles induce robust human T‐helper cell responses
Braun, M., Jandus, C., Maurer, P., Hammann‐Haenni, A., Schwarz, K., Bachmann, M. F., Speiser, D. E., & Romero, P. J. (2011) · European Journal of Immunology · doi:10.1002/eji.201142064 · Cited by 81
CD8 T cell competition for dendritic cells in vivo is an early event in activation
Willis, R. A., Kappler, J. W., & Marrack, P. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605130103 · Cited by 81
Xiao, Y., Peperzak, V., Keller, A. M., & Borst, J. G. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.2.1071 · Cited by 82
BCL6b mediates the enhanced magnitude of the secondary response of memory CD8 + T lymphocytes
Manders, P., Hunter, P., Telaranta, A. I., Carr, J. M., Marshall, J. L., Carrasco, M. J., Murakami, Y., Palmowski, M. J., Cerundolo, V., Kaech, S. M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501585102 · Cited by 81
Tay, N. Q., Lee, D. C. P., Chua, Y. L., Prabhu, N., Gascoigne, N. R. J., & Kemeny, D. M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01484 · Cited by 80
HIV mRNA Vaccines—Progress and Future Paths
Mu, Z., Haynes, B. F., & Cain, D. W. (2021) · Vaccines · doi:10.3390/vaccines9020134 · Cited by 84
Induction and function of virus-specific CD4+ T cell responses
Whitmire, J. K. (2011) · Virology · doi:10.1016/j.virol.2010.12.015 · Cited by 81
Moeller, M., Kershaw, M. H., Cameron, R., Westwood, J. A., Trapani, J. A., Smyth, M. J., & Darcy, P. K. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1141 · Cited by 82
Hombach, A. A., Köhler, H., Rappl, G., & Abken, H. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.8.5668 · Cited by 79
Tumor-intrinsic PIK3CA represses tumor immunogenicity in a model of pancreatic cancer
Sivaram, N., McLaughlin, P. A., Han, H. V., Petrenko, O., Jiang, Y.-P., Ballou, L. M., Pham, K., Liu, C., van der Velden, A. W. M., & Lin, R. Z. (2019) · Journal of Clinical Investigation · doi:10.1172/jci123540 · Cited by 78
Chen, W., & McCluskey, J. (2006) · Advances in cancer research · doi:10.1016/s0065-230x(06)95006-4 · Cited by 78
Costimulation Signals for Memory CD8+ T Cells During Viral Infections
Duttagupta, P. A., Boesteanu, A. C., & Katsikis, P. D. (2009) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v29.i6.20 · Cited by 80
Virus‐specific CD8 T cells: activation, differentiation and memory formation
Wiesel, M., Walton, S. M., Richter, K., & Oxenius, A. (2009) · Apmis · doi:10.1111/j.1600-0463.2009.02459.x · Cited by 80
Snyder, C. M., Loewendorf, A. I., Bonnett, E. L., Croft, M., Benedict, C. A., & Hill, A. B. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900227 · Cited by 79
DNA fusion gene vaccines against cancer: from the laboratory to the clinic
Stevenson, F. K., Rice, J., Ottensmeier, C. H. H., Thirdborough, S. M., & Zhu, D. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00145.x · Cited by 78
Immunostimulatory combinations: designing the next generation of vaccine adjuvants
Kornbluth, R. S., & Stone, G. W. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0306147 · Cited by 79
Bauer, J., Köhler, N., Maringer, Y., Bucher, P., Bilich, T., Zwick, M., Dicks, S., Nelde, A., Dubbelaar, M. L., Scheid, J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33746-3 · Cited by 77
Vaccine-elicited CD4 T cells induce immunopathology after chronic LCMV infection
Penaloza‐MacMaster, P., Barber, D. L., Wherry, E. J., Provine, N. M., Teigler, J. E., Parenteau, L. R., Blackmore, S., Borducchi, E. N., Larocca, R. A., Yates, K. B., et al. (2015) · Science · doi:10.1126/science.aaa2148 · Cited by 76
Leroux‐Roels, I., Koutsoukos, M., Clément, F., Steyaert, S., Janssens, M., Bourguignon, P., Cohen, K. W., Altfeld, M. A., Vandepapelière, P., Pedneault, L., et al. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.08.035 · Cited by 76
Beaumier, C. M., Mathew, A., Bashyam, H., & Rothman, A. L. (2008) · The Journal of Infectious Diseases · doi:10.1086/526790 · Cited by 76
Zappasodi, R., Nicola, M. D., Carlo‐Stella, C., Mortarini, R., Molla, A., Vegetti, C., Albani, S., Anichini, A., & Gianni, A. M. (2008) · Haematologica · doi:10.3324/haematol.12521 · Cited by 77
Effect of Renal Cell Carcinomas on the Development of Type 1 T-Cell Responses
Rayman, P. A., Wesa, A. K., Richmond, A. L., Das, T., Biswas, K., Raval, G. N., Storkus, W. J., Tannenbaum, C. S., Novick, A. C., Bukowski, R. M., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-050011 · Cited by 76
Tritel, M., Stoddard, A. M., Flynn, B. J., Darrah, P. A., Wu, C. Y., Wille, U., Shah, J. A., Huang, Y., Xu, L., Betts, M. R., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.5.2538 · Cited by 76
Distinct CD4 + helper T cells involved in primary and secondary responses to infection
Weber, K. S., Li, Q.-J., Persaud, S. P., Campbell, J. D., Davis, M. M., & Allen, P. M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202408109 · Cited by 75
Interfacing T-cell effector and regulatory function through CD137 (4-1BB) co-stimulation
Myers, L. M., & Vella, A. T. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.06.003 · Cited by 75
Control of CD4+ T‐cell memory by cytokines and costimulators
Dooms, H., & Abbas, A. K. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00387.x · Cited by 74
Tilton, J. C., Luskin, M. R., Johnson, A. J., Manion, M. M., Hallahan, C. W., Metcalf, J. A., McLaughlin, M. E., Davey, R. T., & Connors, M. (2006) · Journal of Virology · doi:10.1128/jvi.01830-06 · Cited by 74
The aryl hydrocarbon receptor is a modulator of anti-viral immunity
Head, J. L., & Lawrence, B. P. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.10.031 · Cited by 80
Bilich, T., Nelde, A., Bichmann, L., Roerden, M., Salih, H. R., Kowalewski, D. J., Schuster, H., Tsou, C., Marcu, A., Neidert, M. C., et al. (2018) · Blood · doi:10.1182/blood-2018-07-866830 · Cited by 74
Deliyannis, G., Kedzierska, K., Lau, Y. F., Zeng, W., Turner, S. J., Jackson, D. C., & Brown, L. E. (2006) · European Journal of Immunology · doi:10.1002/eji.200535217 · Cited by 73
A new murine model to define the critical pathologic and therapeutic mediators of polymyositis
Sugihara, T., Sekine, C., Nakae, T., Kohyama, K., Harigai, M., Iwakura, Y., Matsumoto, Y., Miyasaka, N., & Kohsaka, H. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22521 · Cited by 73
Early events governing memory CD8+ T-cell differentiation
Obar, J. J., & Lefrançois, L. (2010) · International Immunology · doi:10.1093/intimm/dxq053 · Cited by 78
Lyman, M. A., Aung, S., Biggs, J., & Sherman, L. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.6558 · Cited by 73
Recall Responses by Helpless Memory CD8+ T Cells Are Restricted by the Up-Regulation of PD-1
Fuse, S., Tsai, C.-Y., Molloy, M. J., Allie, S. R., Zhang, W., Yagita∥, H., & Usherwood, E. J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802041 · Cited by 74
Immune responsiveness and protective immunity after transplantation
Gangappa, S., Kokko, K. E., Carlson, L. M., Gourley, T. S., Newell, K. A., Pearson, T. C., Ahmed, R., & Larsen, C. P. (2008) · Transplant International · doi:10.1111/j.1432-2277.2007.00631.x · Cited by 73
Belle, T. L. V., Nierkens, S., Arens, R., & von Herrath, M. G. (2012) · Immunity · doi:10.1016/j.immuni.2012.04.005 · Cited by 72
The effect of antigen dose on T cell-targeting vaccine outcome
Billeskov, R., Beikzadeh, B., & Berzofsky, J. A. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1527496 · Cited by 73
Galectin-9 and VISTA Expression Define Terminally Exhausted T Cells in HIV-1 Infection
Shahbaz, S., Dunsmore, G., Koleva, P. T., Xu, L., Houston, S. C., & Elahi, S. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901481 · Cited by 73
den Haan, J. M. M., Kraal, G., & Bevan, M. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.9.5429 · Cited by 72
Giraldo‐Vela, J. P., Rudersdorf, R. A., Chung, C. J., Qi, Y., Wallace, L. T., Bimber, B. N., Borchardt, G. J., Fisk, D. L., Glidden, C. E., Loffredo, J. T., et al. (2007) · Journal of Virology · doi:10.1128/jvi.01816-07 · Cited by 71
Elvang, T. T., Christensen, J. P., Billeskov, R., Hoang, T. T. K. T., Holst, P. J., Thomsen, A. R., Andersen, P. L., & Dietrich, J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005139 · Cited by 71
Charalambous, A., Oks, M., Nchinda, G., Yamazaki, S., & Steinman, R. M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.12.8410 · Cited by 71
Workenhe, S. T., Pol, J. G., Lichty, B. D., Cummings, D. T., & Mossman, K. L. (2013) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0059-t · Cited by 71
Decrease in Measles Virus–Specific CD4 T Cell Memory in Vaccinated Subjects
Naniche, D., Garenne, M., Rae, C. S., Manchester, M., Buchta, R. M., Brodine, S. K., & Oldstone, M. B. A. (2004) · The Journal of Infectious Diseases · doi:10.1086/424571 · Cited by 72
Widenmeyer, M., Griesemann, H., Stevanović, S., Feyerabend, S., Klein, R., Attig, S., Hennenlotter, J., Wernet, D., Kuprash, D. V., Sazykin, A. Y., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.26365 · Cited by 70
Inflammatory cells and their non-coding RNAs as targets for treating myocardial infarction
Jung, M., Dodsworth, M., & Thum, T. (2018) · Basic Research in Cardiology · doi:10.1007/s00395-018-0712-z · Cited by 73
Kremer, A. N., van der Meijden, E. D., van Bergen, C. A. M., Willemze, R., Falkenburg, J. H. F., & Griffioen, M. (2009) · Blood · doi:10.1182/blood-2009-03-208017 · Cited by 70
Sater, H. A., Marté, J. L., Donahue, R. N., Walter-Rodriguez, B., Heery, C. R., Steinberg, S. M., Cordes, L. M., Chun, G., Karzai, F. H., Bilušić, M., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-000655 · Cited by 69
EBV in MS: guilty by association?
Lünemann, J. D., & Münz, C. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.03.007 · Cited by 70
Ex Vivo Phenotype and Frequency of Influenza Virus-Specific CD4 Memory T Cells
Lucas, M., Day, C. L., Wyer, J. R., Cunliffe, S. L., Loughry, A., McMichael, A. J., & Klenerman, P. (2004) · Journal of Virology · doi:10.1128/jvi.78.13.7284-7287.2004 · Cited by 69
Topchyan, P., Lin, S., & Cui, W. (2023) · Immune Network · doi:10.4110/in.2023.23.e41 · Cited by 73
Gerner, M. Y., Casey, K. A., & Mescher, M. F. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.155 · Cited by 71
Yin, W., Gorvel, L., Zurawski, S., Li, D., Ni, L., Duluc, D., Upchurch, K., Kim, J., Gu, C., Ouedraogo, R., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.01.029 · Cited by 69
The interplay between the microbiome and the adaptive immune response in cancer development
Russo, E., Taddei, A., Ringressi, M. N., Ricci, F., & Amedei, A. (2016) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x16635082 · Cited by 68
Kahan, S. M., Bakshi, R. K., Ingram, J. T., Hendrickson, R. C., Lefkowitz, E. J., Crossman, D. K., Harrington, L. E., Weaver, C. T., & Zajac, A. J. (2022) · Science Immunology · doi:10.1126/sciimmunol.abl6322 · Cited by 67
Prasanna, P., Kumar, P., Kumar, S., Rajana, V. K., Kant, V., Prasad, S. R., Mohan, U., Ravichandiran, V., & Mandal, D. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111920 · Cited by 67
Regulatory T cell: a protection for tumour cells
Wang, Y., Ma, Y., Fang, Y., Wu, S., Liu, L., Fu, D., & Shen, X. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01437.x · Cited by 67
Bold, T. D., & Ernst, J. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200994 · Cited by 67
Functional Role of Dendritic Cell Subsets in Cancer Progression and Clinical Implications
Prete, A. D., Sozio, F., Barbazza, I., Salvi, V., Tiberio, L., Laffranchi, M., Gismondi, A., Bosisio, D., Schioppa, T., & Sozzani, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113930 · Cited by 69
T cell responses in melanoma patients after vaccination with tumor-mRNA transfected dendritic cells
Kyte, J. A., Kvalheim, G., Lislerud, K., Straten, P. T., Dueland, S., Aamdal, S., & Gaudernack, G. (2006) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0222-y · Cited by 69
Bachmann, M. F., Hunziker, L., Zinkernagel, R. M., Storni, T., & Köpf, M. (2004) · European Journal of Immunology · doi:10.1002/eji.200324717 · Cited by 67
Metadata
- Authors
- Janssen, E. M., Lemmens, E. E., Wolfe, T., Christen, U., von Herrath, M. G., & Schoenberger, S. P.
- Affiliations
- La Jolla Institute for Immunology (US)
- Corresponding author
- Schoenberger, Stephen P.
- Venue
- Nature
- Published
- 2003-02
- Volume
- 421
- Issue
- 6925
- Pages
- 852-856
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1493822493
- Cited by
- 1,635
- References
- 28
- Citations by year
- 2026: 19 · 2025: 24 · 2024: 37 · 2023: 46 · 2022: 37 · 2021: 42 · 2020: 58 · 2019: 42 · 2018: 52 · 2017: 36 · 2016: 41 · 2015: 61 · 2014: 63 · 2013: 63 · 2012: 71
- FWCI
- 46.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Keywords
- CD4+ T cells, CD8+ T cells, cytotoxic T lymphocytes, T helper cells, secondary immune response, T cell memory, T cell help, cross-priming, antigen-presenting cells, T cell differentiation
- MeSH terms
- Animals, Antigens, Cell Line, Cytotoxicity, Immunologic, Flow Cytometry, T-Lymphocytes, Helper-Inducer, Immunologic Memory, Lymphocyte Activation, Lymphocytic choriomeningitis virus, T-Lymphocytes, Cytotoxic, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review